Chester County News and Community Website
BERWYN, PA — AMETEK Inc. (NYSE: AME) raised its full-year earnings outlook after second-quarter adjusted profit climbed 17% and orders surged 28%, signaling continued demand across semiconductor, aerospace, defense, medical …
AMETEK Raises 2026 Outlook After Earnings Climb 17% Read More
AUDUBON, PA — Globus Medical Inc. (NYSE: GMED) raised its full-year profit outlook after second-quarter revenue climbed 5.9% to $789.6 million, with stronger spine sales and margin expansion offsetting a …
Globus Medical Raises Profit Outlook as Spine Growth Accelerates Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported a $13.2 million second-quarter loss as total revenue fell sharply from a year earlier despite record demand and higher U.S. …
Verrica Revenue Falls Despite Record YCANTH Demand Read More
NEWARK, DE — Artesian Resources Corporation (Nasdaq: ARTNA) posted higher second-quarter earnings and revenue as temporary water-rate increases, customer growth and expanding wastewater operations outweighed higher operating and borrowing costs. …
Artesian Profit Rises as Rates, Customer Growth Lift Revenue Read More
MALVERN, PA — Ocugen Inc. (NASDAQ: OCGN) extended its expected cash runway into 2028 with a $130 million convertible debt financing as the biotechnology company moves one retinal gene therapy …
Ocugen Raises $130 Million as Gene Therapy Trials Advance Read More
WILMINGTON, DE — Acorn Energy Inc. (NASDAQ: ACFN) reported a 29.4% decline in second-quarter revenue as hardware sales to a major telecommunications customer fell sharply, outweighing growth in the company’s …
Acorn Revenue Falls 29% as Hardware Sales Drop Read More
WAYNE, PA — Aclaris Therapeutics Inc. (NASDAQ: ACRS) raised $40.2 million through an at-the-market stock sale after the second quarter, extending its expected cash runway through the end of 2028 …
Aclaris Raises Capital as Drug Pipeline Spending Accelerates Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) is discontinuing development of one cancer drug candidate and concentrating capital on two clinical programs as its second-quarter net loss widened to …
Context Therapeutics Narrows Pipeline as Quarterly Loss Widens Read More
WILMINGTON, DE — Global Indemnity Group LLC (Nasdaq: GBLI) posted an 8% increase in second-quarter net income as lower claims costs and premium growth supported underwriting profitability, while expansion in …
Global Indemnity Profit Rises as Underwriting Improves Read More
MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) reported higher sequential revenue in the second quarter and projected another increase for the current period as orders outpaced shipments across its …
Vishay Revenue Climbs as Orders Point to Further Growth Read More